CombiMatrix Molecular Diagnostics adds scientific advisory board member

May 31, 2006 – Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced that its CombiMatrix group’s wholly-owned subsidiary, CombiMatrix Molecular Diagnostics, has named genomics expert Stephen Scherer to its scientific advisory board.

Scherer is associate chief of research and director of the Center for Applied Genomics at the Hospital for Sick Children, and associate professor of medicine at the University of Toronto.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.